Related Experiment Video
Updated: Jul 9, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
[Bacterial biofilms]
1Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie der Universität Greifswald, Walther-Rathenau-Strasse 43-45, Greifswald. achim.beule@uni-greifswald.de
Abstract:
Today, 65 % of all infections are regarded as a consequence of local biofilms. In Otorhinolaryngology frequent diseases including chronic tonsillitis, chronic sinusitis, otitis media with effusion and cholesteatomas fulfill the clinical criteria of biofilm-associated diseases such as recalcitrant disease, inefficiently treated with long-term antibiotics. Apart from affecting a great proportion of our clinical spectrum, ENT-specialist frequently insert implants into ventilated area such as trachea, middle ear and paranasal sinuses, all susceptible for biofilm attachment. In short, relevant characteristics of biofilms and their development are summarized, clinical knowledge of otorhinolaryngologic diseases is presented and current and future therapeutic approaches are discussed.
Insights
Biofilms cause most infections, particularly in Otorhinolaryngology (ENT) diseases like chronic tonsillitis and sinusitis. Current antibiotic treatments are often ineffective, necessitating new therapeutic strategies for these biofilm-associated conditions.
Area of Science:
- Microbiology and Infectious Diseases
- Otorhinolaryngology
- Biomaterials Science
Context:
- Biofilms are implicated in 65% of all infections.
- Many common Otorhinolaryngology (ENT) conditions, including chronic tonsillitis, chronic sinusitis, otitis media with effusion, and cholesteatomas, exhibit characteristics of biofilm-associated diseases.
- ENT procedures frequently involve implanting devices in areas prone to biofilm formation, such as the trachea, middle ear, and paranasal sinuses.
Purpose:
- To summarize the relevant characteristics and development of biofilms.
- To present clinical knowledge of Otorhinolaryngology diseases linked to biofilms.
- To discuss current and future therapeutic strategies for biofilm-associated infections in ENT.
Summary:
- This review details the nature of biofilms and their role in persistent infections.
- It highlights how conditions like chronic sinusitis and otitis media are often recalcitrant due to biofilms, resisting standard antibiotic therapies.
- The discussion extends to implants used in ENT, which are also susceptible to biofilm colonization.
Impact:
- Provides a comprehensive overview of biofilm challenges in Otorhinolaryngology.
- Emphasizes the limitations of current antibiotic treatments against biofilms.
- Outlines the need for novel therapeutic approaches to effectively manage biofilm-associated diseases and improve patient outcomes in ENT care.
Related Concept Videos
Biofilms
Bacterial Signaling
Microbial Mats
Prokaryotic Cells
Like eukaryotic cells, all prokaryotic cells are surrounded by a plasma membrane, have genetic material in the form of single, circular DNA, a cytoplasm that fills the interior of the cell, and ribosomes that synthesize proteins.

